Welela Tereffe, MD, associate professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, discussed treatment for patients who received neoadjuvant chemotherapy. This review showed that neoadjuvant chemotherapy could risk-stratify patients into
[More]